146 related articles for article (PubMed ID: 3120954)
21. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.
Di Mascio R; Marchioli R; Tognoni G
Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186
[TBL] [Abstract][Full Text] [Related]
22. Use of calcium channel blockers in acute ischemic cerebrovascular disease.
Sood AK; Dua A; Mahajan A; Arora S
J Assoc Physicians India; 1996 Jan; 44(1):70. PubMed ID: 8773106
[No Abstract] [Full Text] [Related]
23. Treating ischemic stroke: is nimodipine the answer?
Ernst E
Clin Pharm; 1992 Apr; 11(4):350-1. PubMed ID: 1563232
[No Abstract] [Full Text] [Related]
24. Double-blind study of nimodipine in non-severe stroke.
Bogousslavsky J; Regli F; Zumstein V; Köbberling W
Eur Neurol; 1990; 30(1):23-6. PubMed ID: 2404768
[TBL] [Abstract][Full Text] [Related]
25. Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.
Langley MS; Sorkin EM
Drugs; 1989 May; 37(5):669-99. PubMed ID: 2663415
[TBL] [Abstract][Full Text] [Related]
26. Hemodynamic and metabolic studies in stroke.
Hakin AM
Semin Neurol; 1989 Dec; 9(4):286-92. PubMed ID: 2518338
[No Abstract] [Full Text] [Related]
27. [Nimodipine in ischemic cerebropathy].
Di Lascio G; Salvini S
Clin Ter; 1993 Feb; 142(2):123-6. PubMed ID: 8472525
[TBL] [Abstract][Full Text] [Related]
28. Clinical testing of compounds modifying acute and chronic neurodegeneration in the CNS.
Etienne P; Hakim A
Prog Clin Biol Res; 1990; 361():387-407. PubMed ID: 2290848
[No Abstract] [Full Text] [Related]
29. Treating acute ischaemic stroke.
Bath PM
BMJ; 1995 Jul; 311(6998):139-40. PubMed ID: 7613412
[No Abstract] [Full Text] [Related]
30. Are more complex study designs needed for future acute stroke trials?
Mohr JP; Mast H; Thompson JL; Sacco RL
Cerebrovasc Dis; 1998 Jan; 8 Suppl 1():17-22. PubMed ID: 9547023
[No Abstract] [Full Text] [Related]
31. Effect of nimodipine on acute ischemic stroke. Pooled results from five randomized trials.
Gelmers HJ; Hennerici M
Stroke; 1990 Dec; 21(12 Suppl):IV81-4. PubMed ID: 2260153
[TBL] [Abstract][Full Text] [Related]
32. Association of glycerol to dexamethasone in treatment of stroke patients.
Albizzati MG; Candelise L; Capitani E; Colombo A; Spinnler H
Acta Neurol Scand; 1979 Aug; 60(2):77-84. PubMed ID: 495045
[TBL] [Abstract][Full Text] [Related]
33. Cerebral metabolic effects of glycerol infusion in diabetics with stroke.
Meyer JS; Shimazu K; Ouchi T; Okamoto S; Koto A; Fukuuchi Y; Ericsson AD
J Neurol Sci; 1974 Jan; 21(1):1-22. PubMed ID: 4443814
[No Abstract] [Full Text] [Related]
34. The placebo effect. Drug trial considerations.
McLean J
Nurs Times; 1990 Apr 25-May 1; 86(17):31-3. PubMed ID: 2185458
[No Abstract] [Full Text] [Related]
35. Naftidrofuryl in the treatment of subacute stroke.
Capon A; Lehert P; Opsomer L
J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S62-6. PubMed ID: 1369722
[TBL] [Abstract][Full Text] [Related]
36. Reversible cerebral angiopathy: efficacy of nimodipine.
Zuber M; Touzé E; Domigo V; Trystram D; Lamy C; Mas JL
J Neurol; 2006 Dec; 253(12):1585-8. PubMed ID: 17063316
[TBL] [Abstract][Full Text] [Related]
37. Update on calcium antagonists in cerebrovascular diseases.
Toni D; Frontoni M; Argentino C; Sacchetti ML; De Michele M; Fieschi C
J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S10-4. PubMed ID: 1726729
[TBL] [Abstract][Full Text] [Related]
38. [The administration of calcium channel blockers in patients with cerebrovascular diseases].
Keppel Hesselink JM
Ned Tijdschr Geneeskd; 1989 Jan; 133(4):180-1. PubMed ID: 2922083
[No Abstract] [Full Text] [Related]
39. Glycerol and stroke.
Rubegni M; Provvedi D
Lancet; 1973 Feb; 1(7800):433. PubMed ID: 4119751
[No Abstract] [Full Text] [Related]
40. Use of calcium channel blockers in acute ischemic cerebrovascular disease.
Dalal PM; Dalal KP
J Assoc Physicians India; 1995 Jun; 43(6):394-7. PubMed ID: 8906943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
